Table 1.
Summary of tracer injections from current study and previously published data (Smith and Alloway, 2010).
Case | Left hemisphere | Right hemisphere | ||
---|---|---|---|---|
Motor region | Sensory region | Motor region | Sensory region | |
TI-14 | – | V1 (FR) | FEF (FG/BDA) | V1 (TB) |
TI-15 | FEF (BDA) | V1 (FR) | FEF (FG) | V1 (TB) |
TI-16 | FEF (BDA) | V1 (FR) | FEF (FG) | V1 (TB) |
CL-01 | M1-Re (FR) | – | M1-Re (FG) | – |
CL-02 | M1-Re (FR) | – | M1-Re (FG) | – |
CL-03 | M1-Fp (FR) | – | M1-Fp (FG) | – |
CL-04 | M1-Fp (FR) | – | M1-Fp (FG) | – |
CL-05 | M1-Re (FR) | – | M1-Re (FG) | – |
CL-06 | M1-Fp (FR) | – | M1-Fp (FG) | – |
CL-21 | M1-RW (FR) | – | M1-RW (FG) | – |
CL-22 | M1-RW (FR) | – | M1-RW (FG) | – |
CL-23 | M1-RW (FR) | – | M1-RW (FG) | – |
Anterograde tracers: BDA, biotinylated dextran amine; FR, FluoroRuby.
Retrograde tracers: FG, FluoroGold; TB, True Blue Chloride.